Home Brand Positioning Page 16

Brand Positioning

Random

Patient comparing branded, generic, and compounded medications in a modern pharmaceutical setting representing healthcare decision-making and FDA oversight.

Compounded vs. Branded vs. Generic: The New Battle for Patient Understanding

Donna Pacheco - May 11, 2026

1...14 1516Page 16 of 16

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Scientist analyzing biomarker data and DNA diagnostics in a modern laboratory, illustrating biomarker diagnostic marketing and precision medicine strategies in the pharmaceutical industry.

Marketing the Biomarker Before the Brand: Pharma’s New Growth Strategy

June 23, 2026

Climate-driven disease spread visualized through predictive healthcare analytics, showing emerging infectious disease risk zones and pharmaceutical marketing intelligence.

When Diseases Move North: The New Geography of Pharma Marketing

June 23, 2026

GLP-1 injection pen, medication vial, and safety warning materials illustrating overdose concerns, dosing errors, and pharmaceutical risk communication challenges.

The GLP-1 Safety Reckoning: Why Overdose Headlines Are Becoming a Marketing...

June 22, 2026